Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Busy address KBO
21 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Newton Biocapital II Partners from Sint-Pieters-Woluwe, company number BE0767828541, closed financial year 2025 with a result of € 4,082 after tax. For that financial year Newton Biocapital II Partners recorded a gross margin of € 8,285 and equity of € -10,112. Compared with financial year 2024, the result moved from € 63,752 to € 4,082. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.
€ -10,112
▲ € 4,082 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,082
▼ 94% vs 2024
Profit after tax over the fiscal year.
€ 44,927
▼ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -18,112.
People and assets in 2025
€ 2,074
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 57,435
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,869
▼ 73% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -174,384 | € 93,587 | € 73,216 | € 8,285 | ▼ 89% |
| Profit after taxes | € -175,540 | € 91,371 | € 63,752 | € 4,082 | ▼ 94% |
| Equity | € -169,316 | € -77,945 | € -14,194 | € -10,112 | ▲ € 4,082 |
| Total debts | € 172,613 | € 146,128 | € 85,090 | € 59,336 | ▼ 30% |
| Cash | € 3,285 | € 36,927 | € 69,095 | € 44,927 | ▼ 35% |
| Retained profit | € -177,316 | € -85,945 | € -22,194 | € -18,112 | ▲ € 4,082 |
| Balance sheet total | € 3,297 | € 68,183 | € 70,897 | € 49,225 | ▼ 31% |
Key figures of Newton Biocapital II Partners, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Newton Biocapital II Partners?
What happened at Newton Biocapital II Partners in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4,082 (▼ 94% vs 2024). Source: NBB ↗
- ROAD MEDICAL GODOKAISHA S. Etr. became a director. NBB
- BIOSS S. Etr. became a director. NBB
- New establishment in Sint-Pieters-Woluwe. KBO
- DANNY GONNISSEN SRL became a director. NBB
- HEYNEN CONSULTING AG S. Etr. became a director. NBB
- A Q INVEST SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 175,540 loss in 2022 to € 4,082 profit in 2025.
Paid € 8,717 in corporate taxes since 2022.
Best year ever: 2023, with € 91,371 profit.
Management
The stake of DANNY GONNISSEN, A Q INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Newton Biocapital II PartnersBehind Newton Biocapital II Partners are DANNY GONNISSEN SRL, HEYNEN CONSULTING AG S. Etr., ROAD MEDICAL GODOKAISHA S. Etr., A Q INVEST SRL and BIOSS S. Etr.. The shares are held by DANNY GONNISSEN (20%) and A Q INVEST (16.9%).
Directors
According to the 2025 annual accounts
Director · represented by Danny GONNISSEN
Also active at: Newton Biocapital I Investment Pool, QBIC Venture Partners
since 2021
Director · represented by Guillaume HEYNEN
Also active at: Newton Biocapital Partners
since 2021
ROAD MEDICAL GODOKAISHA S. Etr.
Director · represented by Wada MICHIHIKO
since 2024
Director · represented by Alain PARTHOENS
Also active at: Ncardia Holding, Newton Biocapital Partners, Newton Biocapital I Investment Pool, DEXOWL
since 2021
BIOSS S. Etr.
Director · represented by Sadashi SUZUKI
since 2022
Shareholders
20%
16.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Tervurenlaan 273
1150 Sint-Pieters-Woluwe
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
All companies at this address →BELGIAN RISK MANAGEMENT ASSOCIATION
European Coil Coating Association
€ 877,191 revenue · 2025
FEDERATION EUROPEENNE DE RISK MANAGEMENT - FEDERATION OF EUROPEAN RISK MANAGEMENT ASSOCIATIONS
€ 3.2 million revenue · 2024
LATOUR & PETIT
€ 1.5 million gross margin · 2025
AQ PARTNERS
€ 69,850 gross margin · 2025
+16 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0767.828.541
- VAT number
- BE 0767.828.541
- Registered office
- Tervurenlaan 273, 1150 Sint-Pieters-Woluwe
- Names & denominations
- Newton Biocapital II Partners
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 May 2021
- Peppol
- Active · Active since 29 Jan 2026
- Activities · NACE
Overige financiële dienstverlening, neg